Comparative study of chocolate balloon versus conventional balloon on vessel preparation for femoropopliteal artery diseases: Propensity score-matched analysis of the CIVILIAN registry
Abstract OBJECTIVE: The objective of this study was to compare the safety and effectiveness of Chocolate and conventional balloons for vessel preparation followed by drug-coated balloon (DCB) in femoropopliteal (FP) artery disease. METHODS: This was a retrospective, multi-centered real-world study. Patients’ data of demographics, lesions, and peri-procedural characteristics were consecutively collected between August 2021 and December 2022. All patients were matched through propensity score matched (PSM) analysis. Primary endpoints included the rate of flow-limiting dissections after ultimate dilatation. Secondary endpoints were the rate of bailout stenting and freedom from clinically driven target lesion revascularization (CD-TLR) at 6-month follow-up. RESULTS: Patients were finally divided into the Chocolate percutaneous transluminal angioplasty (PTA) ( n = 148) and the conventional balloon ( n = 148) groups after PSM. Regarding the primary endpoint, rates of flow-limiting dissections were slightly lower in the Chocolate PTA group (19.6% vs. 20.3%, P = 0.88). Sub-analysis also showed similar trends in the two groups without sequential dilatation. The rate of flow-limiting dissections was significantly lower in the Chocolate PTA group without combining predilatation (11.7% and 13.3%, P = 0.04). Predictors of bailout stenting in the Chocolate PTA group were chronic limb ischemia, severe calcification, and TASCII C/D. The overall freedom from CD-TLR rate during follow-up was 100% and 98.0% ±1.2% in the Chocolate and conventional groups, respectively ( P = 0.08). CONCLUSION: Chocolate balloon combined with DCB resulted in a comparable reduced rate of severe dissections and bailout stenting in FP disease patients compared with conventional balloon, especially when combing with non-sequential dilatation. Meanwhile, the Chocolate balloon could achieve significant better outcomes for vessel preparation without performing predilatation.
Authors
- Weijian Fan (ORCID: https://orcid.org/0000-0002-9302-1622)
- Zibo Feng (ORCID: https://orcid.org/0009-0006-2940-8095)
- Chunshui He (ORCID: https://orcid.org/0000-0003-0623-5882)
- Ziheng Wu
- Zhenyu Shi (ORCID: https://orcid.org/0000-0002-9150-5674)
- Meng Ye (ORCID: https://orcid.org/0000-0002-8125-6854)
- Xin Fang (ORCID: https://orcid.org/0000-0002-0218-7310)
- Lianrui Guo
- Weihao Shi
- Shuangshuang Lu
Institutions
- Capital Medical University (CN)
- Fudan University (CN)
- Renji Hospital (CN)
- Zhongshan Hospital (CN)
- Affiliated Hangzhou First People's Hospital, Westlake University, School of Medicine (CN)
- Huashan Hospital (CN)
- First Affiliated Hospital Zhejiang University (CN)
- Huazhong University of Science and Technology (CN)
- Chengdu University of Traditional Chinese Medicine (CN)
- Zhejiang University (CN)
Publication Details
- Journal
- Vascular Investigation and Therapy
- Published
- 2024-10-01
- DOI
- https://doi.org/10.4103/vit.vit_29_24
- Primary Topic
- Peripheral Artery Disease Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00